Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
BN.1.2.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BN.1.4EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BF.11.4EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.14EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BE.4.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
GM.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BQ.1.1.20EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BQ.1.26EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.129 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XAY.2.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BF.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BF.7.10EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
CM.8.1.4EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BF.7.5.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BE.1.2.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BF.7.7EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BQ.1.1.34EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.4.7EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
CH.1.1.5EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BF.7.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.15.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BF.7.20EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.9.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FA.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
ER.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.4.1.11EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
CQ.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.5.2.13EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.5.3.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.5.2.7EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BE.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BQ.1.1.9EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BF.11.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBF.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BZ.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BQ.1.10.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BF.7.24EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.5.10EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.44EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BE.1.4EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BF.7.4.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.5.5.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.37EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.5.2.57EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
CN.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.4.5EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.54EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BF.18EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.52EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BL.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used